Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

International Business Machines (IBM)

2026-08-19T14:26:12.078854+00:00

Key Updates

IBM shares have advanced 2.25% since the August 17 report, rising from $231.60 to $236.81, supported by a 1.78% gain in the most recent session and a broader 1-month rally of 11.18%. No new material news events were identified beyond a routine Form 8-K (Item 9.01) filed August 14, 2026, which contains no disclosed financial metrics. The rebound reverses the breakdown below the $232.85 support level flagged in the prior report, with price now testing the upper boundary of the $232.85–$238.44 range established in mid-August.

Current Trend

IBM remains down 20.05% YTD and 7.60% over six months, reflecting the impact of the July 22 guidance cut and subsequent selloff. However, short-term momentum has turned positive: the stock has recovered the $232.85 level that previously acted as support before breaking down, and is now approaching the $238.44 resistance from the August 13 trading range. The 1-month gain of 11.18% indicates a technical recovery from oversold conditions following the post-earnings decline, though the stock remains well below pre-guidance-cut levels on a YTD basis.

Investment Thesis

The core thesis remains centered on IBM's entrenched infrastructure position—mainframes, servers, and software embedded in critical financial-system backend processes, including credit card authorization networks—providing a stabilizing, utility-like revenue base even amid capital-budget shifts toward AI infrastructure. Management has maintained free cash flow growth guidance of approximately $1 billion for 2026 despite the Q2 revenue and EPS miss, supporting confidence in underlying cash generation. However, the accelerating erosion in mainframe (IBM Z down 42%) and infrastructure revenue (down 7%) signals structural pressure from customers reallocating budgets to AI infrastructure, a risk that remains unresolved.

Thesis Status

The thesis is intact but unconfirmed by fundamentals. The recent price recovery is technical in nature—driven by a rebound from oversold levels rather than new positive fundamental catalysts—since no earnings or guidance updates have been released since the July 22 cut. The maintained FCF guidance continues to underpin the utility/resilience narrative articulated by IBM's CEO, but the absence of new data means the guidance-cut concerns from late July remain the dominant fundamental overhang. The thesis should be considered range-bound pending the next earnings update or further clarity on mainframe/software demand trends.

Key Drivers

The dominant driver remains the July 22 guidance cut, where IBM lowered FY26 constant-currency revenue growth guidance to 4-5% from over 5%, citing a 42% plunge in IBM Z mainframe sales and a 7% decline in infrastructure revenue to $3.84 billion (SiliconANGLE). This was corroborated by the Q2 10-Q filing showing revenue of $17.16 billion (+1% YoY) and diluted EPS of $2.27 (-2% YoY) (SEC EDGAR). The related 8-K filing on July 22 formalized these results disclosures (SEC EDGAR). CEO commentary published July 23 reinforced confidence in IBM's resilience as a critical infrastructure provider despite the broader market selloff (The Wall Street Journal). A subsequent routine 8-K filed August 14 disclosed no new financial details (SEC EDGAR).

Technical Analysis

IBM trades at $236.81, up 1.78% intraday and 2.25% since the last report, recovering above the $232.85 level that previously served as support before failing in mid-August. The stock is now approaching the $238.44 resistance level from the prior consolidation range. The 1-month gain of 11.18% signals a strong short-term recovery, though the 6-month (-7.60%) and YTD (-20.05%) figures confirm the stock remains in a broader downtrend. A sustained break above $238.44 would be the next technical confirmation of a trend reversal; failure to hold above $232.85 would reassert bearish momentum.

Bull Case

  • Management maintained full-year free cash flow growth guidance of approximately $1 billion despite the Q2 miss, indicating cash generation resilience (SiliconANGLE)
  • Software revenue grew 5% YoY to $7.76 billion in Q2, supporting the recurring-revenue base (SiliconANGLE)
  • Consulting revenue increased 1% at constant currency to $5.3 billion, showing modest growth in services (SiliconANGLE)
  • CEO emphasized IBM's utility-like, deeply entrenched infrastructure role in critical financial-system processing, positioning the company as a stabilizing asset in volatile markets (The Wall Street Journal)
  • Stock has rebounded 11.18% over the past month and reclaimed the $232.85 support level, signaling near-term technical strength (price data)

Bear Case

  • IBM cut its FY26 constant-currency revenue growth guidance to 4-5% from over 5%, with reported growth expected near zero due to currency effects (SiliconANGLE)
  • IBM Z mainframe sales plunged 42% as customers shifted capital budgets toward AI infrastructure (SiliconANGLE)
  • Infrastructure revenue declined 7% YoY to $3.84 billion, reflecting structural demand shift away from legacy hardware (SiliconANGLE)
  • Q2 revenue of $17.16 billion and adjusted EPS of $2.93 both missed consensus estimates ($17.58 billion and $2.97, respectively), with net income declining 1% YoY (SiliconANGLE)
  • Stock remains down 20.05% YTD and 7.60% over six months, indicating the recent rebound has not offset the broader downtrend triggered by the guidance cut (price data)

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.